The Post-Operative Nausea And Vomiting Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Post-Operative Nausea And Vomiting Market?
The post-operative nausea and vomiting market has seen substantial growth recently. It is projected to increase from $2.11 billion in 2024 to $2.26 billion in 2025, with a compound annual growth rate (CAGR) of 7.4%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Post-Operative Nausea And Vomiting Industry?
The global market for post-operative nausea and vomiting is projected to reach $2.97 billion in 2029, experiencing a compound annual growth rate (CAGR) of 7.0%.
Download Your Free Sample of the 2025 Post-Operative Nausea And Vomiting Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Post-Operative Nausea And Vomiting Market?
The key drivers in the post-operative nausea and vomiting market are:
• Growing demand for pharmaceuticals
• Increase in combination therapy
• Rising awareness and healthcare investment
• Increased geriatric population and rising number of cancer cases
Global Market Segmentation: Identifying Major Post-Operative Nausea And Vomiting Industry Segments
The post-operative nausea and vomiting market covered in this report is segmented –
1) By Treatment Type: Serotonin Antagonists, Steroids, Dopamine Antagonists, Neurokinin NK-1 Receptor Antagonists, Non-pharmacological Treatment, Other Treatment Types
2) By Route Of Administration: Oral, Intravenous, Transdermal, Other Route Of Administrations
3) By Patient Demographics: Pediatric Patients, Adult Patients, Geriatric Patients
4) By Surgical Procedure Type: Orthopedic Surgery, Gynecological Surgery, General Surgery, Cardiac Surgery, Ophthalmic Surgery
5) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users
Subsegments:
1) By Serotonin Antagonists Type: Ondansetron, Granisetron, Palonosetron, Dolasetron, Tropisetron
2) By Steroids Type: Dexamethasone, Methylprednisolone, Hydrocortisone, Prednisolone, Betamethasone
3) By Dopamine Antagonists Type: Metoclopramide, Droperidol, Prochlorperazine, Domperidone, Chlorpromazine
4) By Neurokinin NK-1 Receptor Antagonists Type: Aprepitant, Fosaprepitant, Rolapitant, Netupitant, Casopitant
5) By Non-Pharmacological Treatment Type: Acupressure, Aromatherapy, Hypnotherapy, Electroacupuncture, Ginger Supplements
6) By Other Treatment Types: Antihistamines, Anticholinergics, Cannabinoids, Combination Therapy, Herbal & Natural Remedies
Pre-order the 2025 Post-Operative Nausea And Vomiting Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Post-Operative Nausea And Vomiting Market?
The key trends in the post-operative nausea and vomiting market are:
• Advanced antiemetic therapies are emerging as a significant trend.
• Strategic collaborations are shaping the future of the post-operative nausea and vomiting market.
• Innovative drug formulations are rising as an emerging trend.
• The integration of advanced diagnostic tools and electronic simulation devices is becoming increasingly influential.
Who Are the Top Competitors & Leading Players in the Post-Operative Nausea And Vomiting Market?
Major players in the post-operative nausea and vomiting market are:
• Pfizer Inc.
• Merck KGaA
• Novartis AG
• GlaxoSmithKline Plc
• Takeda Pharmaceutical Company Limited
• Baxter Corporation
• Teva Pharmaceutical Industries Ltd.
• Sandoz Group AG
• Daiichi Sankyo Inc.
• Fresenius Kabi AG
• Eisai Co. Ltd.
• Dr. Reddy's Laboratories
• Kyowa Hakko Kirin Taiwan Co. Ltd.
• Cipla Ltd.
• Alkem Laboratories Ltd.
• Eagle Pharmaceuticals Inc.
• Camurus AB
• Helsinn Healthcare SA
• Heron Therapeutics Inc.
• Advacare Pharma
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the post-operative nausea and vomiting market in 2024
